OTCMCNHC
Market cap324kUSD
Dec 19, Last price
0.00USD
Name
China Health Management Corp
Chart & Performance
P/E
—
P/S
6.54
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
—
Rev. gr., 5y
-55.01%
Revenues
50k
+80.98%
Net income
-78k
L+8,876.83%
CFO
42k
+22.16%
Profile
China Health Management Corp. operates as a healthcare and management company in China. It focuses on the operation and management of hospitals. The company provides healthcare services in the areas of gynaecology and obstetrics, paediatrics, stomatology, dermatology, medical cosmetology, pathology, ophthalmology and otolaryngology, anesthesia, and haemodialysis. Its services also include surgery, emergency medicine, intensive care, preventive medicine, pharmacy, psychological consultation therapy, medical consultation, combined Chinese and Western medicine, medical examination, medical imaging, medical functions examination, commissioning hospital management, hospital management consultation, etc. The company was formerly known as Max Internet Communications, Inc. and changed its name to China Health Management Corp. in March 2006. China Health Management Corp. was incorporated in 1996 and is based in Dallas, Texas.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | |
| Income | ||||||
Revenues | 50 80.98% | 27 | ||||
Cost of revenue | 3 | |||||
Unusual Expense (Income) | ||||||
NOPBT | 46 | 27 | ||||
NOPBT Margin | 93.33% | 100.00% | ||||
Operating Taxes | (132) | 3 | (237) | |||
Tax Rate | 11.49% | |||||
NOPAT | 46 | 24 | 237 | |||
Net income | (78) 8,876.83% | (872) -90.26% | (9) | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 6 | |||||
BB yield | -1.04% | |||||
| Debt | ||||||
Debt current | 662 | 718 | 17 | |||
Long-term debt | ||||||
Deferred revenue | ||||||
Other long-term liabilities | ||||||
Net debt | (540) | 705 | 17 | |||
| Cash flow | ||||||
Cash from operating activities | 42 | 34 | (8) | |||
CAPEX | 3 | |||||
Cash from investing activities | 13 | |||||
Cash from financing activities | (41) | (34) | 8 | |||
FCF | 1,419 | (664) | ||||
| Balance | ||||||
Cash | 14 | 13 | ||||
Long term investments | 1,189 | |||||
Excess cash | 1,200 | 11 | ||||
Stockholders' equity | (27,847) | (27,718) | (27,804) | |||
Invested Capital | 28,348 | 28,404 | 27,802 | |||
ROIC | 0.16% | 0.09% | 0.85% | |||
ROCE | 9.23% | 3.99% | ||||
| EV | ||||||
Common stock shares outstanding | 81,146 | 81,146 | 81,146 | |||
Price | 0.01 -37.70% | 0.01 | ||||
Market cap | 617 -37.70% | 990 | ||||
EV | 1,325 | 1,007 | ||||
EBITDA | 50 | 27 | ||||
EV/EBITDA | 48.37 | |||||
Interest | 38 | 7 | ||||
Interest/NOPBT | 81.23% | 24.13% | ||||